结核病预防治疗的 3 HP 方案：在印度等国大规模实施期间的安全性、剂量和相关问题

{"title":"结核病预防治疗的 3 HP 方案：在印度等国大规模实施期间的安全性、剂量和相关问题","authors":"Anurag Bhargava","doi":"10.1016/j.lansea.2024.100422","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":508974,"journal":{"name":"The Lancet Regional Health - Southeast Asia","volume":"48 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The 3 HP regimen for tuberculosis preventive treatment: safety, dosage and related concerns during its large-scale implementation in countries like India\",\"authors\":\"Anurag Bhargava\",\"doi\":\"10.1016/j.lansea.2024.100422\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":508974,\"journal\":{\"name\":\"The Lancet Regional Health - Southeast Asia\",\"volume\":\"48 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet Regional Health - Southeast Asia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.lansea.2024.100422\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Regional Health - Southeast Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.lansea.2024.100422","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}